FluoroPharma Medical Share Holder Equity 2010-2016 | FPMI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

FluoroPharma Medical share holder equity from 2010 to 2016. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

FluoroPharma Medical share holder equity from 2010 to 2016. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$195.6B
Stryker (SYK)	$137.3B
Boston Scientific (BSX)	$122.7B
Medtronic (MDT)	$114.6B
EssilorLuxottica (ESLOY)	$108.8B
Haleon (HLN)	$48.7B
Lonza Group Ag (LZAGY)	$46B
ResMed (RMD)	$35.1B
Koninklijke Philips (PHG)	$30.8B
Terumo (TRUMY)	$28.5B
Zimmer Biomet Holdings (ZBH)	$22B
Baxter (BAX)	$19.9B
Insulet (PODD)	$16.3B
Smith & Nephew SNATS (SNN)	$13.6B
Bio-Rad Laboratories (BIO)	$9.2B
Demant (WILYY)	$8.7B
BellRing Brands (BRBR)	$7.9B
Lantheus Holdings (LNTH)	$7.5B
ICU Medical (ICUI)	$4.3B
Haemonetics (HAE)	$4.1B
TG Therapeutics (TGTX)	$3.7B
Neogen (NEOG)	$3.6B
Prestige Consumer Healthcare (PBH)	$3.5B
GN Store Nord (GNNDY)	$3.5B
Perrigo (PRGO)	$3.5B
Envista Holdings (NVST)	$3.4B
QuidelOrtho (QDEL)	$3.1B
Agios Pharmaceuticals (AGIO)	$2.6B
Green Thumb Industries (GTBIF)	$2.2B
Maravai LifeSciences Holdings (MRVI)	$2.1B